Euformatics Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 17

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $370K

  • Investors
  • 3

Euformatics General Information

Description

Developer of bioinformatics tools designed to help in genomic data quality management and interpretation. The company's tools facilitate test optimization, familiarisation and validation processes to be used before and during the formal process of assay validation, enabling medical professionals and molecular genetics laboratories to provide precision medicine for cancer and common or rare disease diagnostics.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Tekniikantie 12
  • 02150 Espoo
  • Finland
+358 040
Primary Industry
Other Healthcare Technology Systems
Other Industries
Discovery Tools (Healthcare)
Biotechnology
Business/Productivity Software
Vertical(s)
Corporate Office
  • Tekniikantie 12
  • 02150 Espoo
  • Finland
+358 040

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Euformatics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 01-Jul-2022 $370K Completed Profitable
3. Angel (individual) 30-Sep-2020 Completed Profitable
2. Grant 01-Oct-2018 $816K $392K Completed Profitable
1. Seed Round 20-Sep-2016 $392K $392K Completed Profitable
To view Euformatics’s complete valuation and funding history, request access »

Euformatics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
To view Euformatics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Euformatics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Euformatics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
European Commission's Recovery and Resilience Facility Government Minority
Horizon 2020 SME Instrument Government Minority
Tekes Not-For-Profit Venture Capital Minority
To view Euformatics’s complete investors history, request access »

Euformatics FAQs

  • When was Euformatics founded?

    Euformatics was founded in 2010.

  • Where is Euformatics headquartered?

    Euformatics is headquartered in Espoo, Finland.

  • What is the size of Euformatics?

    Euformatics has 17 total employees.

  • What industry is Euformatics in?

    Euformatics’s primary industry is Other Healthcare Technology Systems.

  • Is Euformatics a private or public company?

    Euformatics is a Private company.

  • What is Euformatics’s current revenue?

    The current revenue for Euformatics is .

  • How much funding has Euformatics raised over time?

    Euformatics has raised $422K.

  • Who are Euformatics’s investors?

    European Commission's Recovery and Resilience Facility, Horizon 2020 SME Instrument, and Tekes have invested in Euformatics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »